Paper833869
IgG4 subclass in malignant melanoma.
Daveau M and 7 others. J Natl Cancer Inst, 1977. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. IgG4 subclass in malignant melanoma. Papers, record 833869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/833869
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunoglobulin G | Major topic |
| Melanoma | Major topic |
| Skin Neoplasms | Major topic |
| Female | |
| Humans | |
| Immunoglobulin Allotypes | |
| Male |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41954969 | Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of haematopoietic malignancies with insights into pathogenic mechanisms. | Oncotarget | 2026 | https://conductscience.org/library/papers/41954969 | PubMed |
| 40977881 | IMGT® analysis of the human IGH locus: unveiling novel polymorphisms and copy number variations in 15 genome assemblies from diverse ancestral backgrounds. | NAR Genom Bioinform | 2025 | https://conductscience.org/library/papers/40977881 | PubMed |
| 40592566 | The dual role of IgG4 in immunity: bridging pathophysiology and therapeutic applications. | Gut | 2025 | https://conductscience.org/library/papers/40592566 | PubMed |
| 40484866 | Adaptive immune changes in colorectal cancer: a focus on T and B cell activation genes. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40484866 | PubMed |
| 40449958 | Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40449958 | PubMed |
| 40358163 | Role of IgG4 Antibodies in Human Health and Disease. | Cells | 2025 | https://conductscience.org/library/papers/40358163 | PubMed |
| 37652365 | Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation. | Biochim Biophys Acta Gen Subj | 2023 | https://conductscience.org/library/papers/37652365 | PubMed |
| 37243095 | IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37243095 | PubMed |
| 37095254 | The unique properties of IgG4 and its roles in health and disease. | Nat Rev Immunol | 2023 | https://conductscience.org/library/papers/37095254 | PubMed |
| 36211808 | Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies. | Oncoimmunology | 2022 | https://conductscience.org/library/papers/36211808 | PubMed |
| 35218154 | A B-cell or a key player? The different roles of B-cells and antibodies in melanoma. | Pigment Cell Melanoma Res | 2022 | https://conductscience.org/library/papers/35218154 | PubMed |
| 34725991 | Intracranial Tumors Associated With IgG4-Related Disease. | Brain Tumor Res Treat | 2021 | https://conductscience.org/library/papers/34725991 | PubMed |
| 34382595 | Lung adenocarcinoma misdiagnosed as IgG4-related lung disease: A case report and literature review. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2021 | https://conductscience.org/library/papers/34382595 | PubMed |
| 33753489 | Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/33753489 | PubMed |
| 33569063 | B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies. | Front Immunol | 2020 | https://conductscience.org/library/papers/33569063 | PubMed |
| 31737561 | Serum IgG Is Associated With Risk of Melanoma in the Swedish AMORIS Study. | Front Oncol | 2019 | https://conductscience.org/library/papers/31737561 | PubMed |
| 29377160 | IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders. | Ann N Y Acad Sci | 2018 | https://conductscience.org/library/papers/29377160 | PubMed |
| 27222052 | Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models. | Cancer Immunol Immunother | 2016 | https://conductscience.org/library/papers/27222052 | PubMed |
| 26951261 | A high number of IgG4-positive cells in gastric cancer tissue is associated with tumor progression and poor prognosis. | Virchows Arch | 2016 | https://conductscience.org/library/papers/26951261 | PubMed |
| 26742760 | IgG4 Characteristics and Functions in Cancer Immunity. | Curr Allergy Asthma Rep | 2016 | https://conductscience.org/library/papers/26742760 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/833869
GET https://conductscience.org/api/papers/v1/833869/cited_by?page=2